867 related articles for article (PubMed ID: 24093431)
1. Lyophilized insulin nanoparticles prepared from quaternized N-aryl derivatives of chitosan as a new strategy for oral delivery of insulin: in vitro, ex vivo and in vivo characterizations.
Mahjub R; Radmehr M; Dorkoosh FA; Ostad SN; Rafiee-Tehrani M
Drug Dev Ind Pharm; 2014 Dec; 40(12):1645-59. PubMed ID: 24093431
[TBL] [Abstract][Full Text] [Related]
2. In-vitro and in-vivo cytotoxicity and efficacy evaluation of novel glycyl-glycine and alanyl-alanine conjugates of chitosan and trimethyl chitosan nano-particles as carriers for oral insulin delivery.
Jafary Omid N; Bahari Javan N; Dehpour AR; Partoazar A; Rafiee Tehrani M; Dorkoosh F
Int J Pharm; 2018 Jan; 535(1-2):293-307. PubMed ID: 29138048
[TBL] [Abstract][Full Text] [Related]
3. Insulin-loaded nanoparticles based on N-trimethyl chitosan: in vitro (Caco-2 model) and ex vivo (excised rat jejunum, duodenum, and ileum) evaluation of penetration enhancement properties.
Sandri G; Bonferoni MC; Rossi S; Ferrari F; Boselli C; Caramella C
AAPS PharmSciTech; 2010 Mar; 11(1):362-71. PubMed ID: 20232266
[TBL] [Abstract][Full Text] [Related]
4. N-trimethyl chitosan chloride-coated PLGA nanoparticles overcoming multiple barriers to oral insulin absorption.
Sheng J; Han L; Qin J; Ru G; Li R; Wu L; Cui D; Yang P; He Y; Wang J
ACS Appl Mater Interfaces; 2015 Jul; 7(28):15430-41. PubMed ID: 26111015
[TBL] [Abstract][Full Text] [Related]
5. Preparation and optimization of N-trimethyl-O-carboxymethyl chitosan nanoparticles for delivery of low-molecular-weight heparin.
Mahjub R; Heidari Shayesteh T; Radmehr M; Vafaei SY; Amini M; Dinarvand R; Dorkoosh FA
Pharm Dev Technol; 2016; 21(1):14-25. PubMed ID: 25255172
[TBL] [Abstract][Full Text] [Related]
6. Preparation, statistical optimization, and in vitro characterization of insulin nanoparticles composed of quaternized aromatic derivatives of chitosan.
Mahjub R; Dorkoosh FA; Amini M; Khoshayand MR; Rafiee-Tehrani M
AAPS PharmSciTech; 2011 Dec; 12(4):1407-19. PubMed ID: 22033812
[TBL] [Abstract][Full Text] [Related]
7. Nanoparticles of quaternized chitosan derivatives as a carrier for colon delivery of insulin: ex vivo and in vivo studies.
Bayat A; Dorkoosh FA; Dehpour AR; Moezi L; Larijani B; Junginger HE; Rafiee-Tehrani M
Int J Pharm; 2008 May; 356(1-2):259-66. PubMed ID: 18289808
[TBL] [Abstract][Full Text] [Related]
8. Preparation, characterization, and oral delivery of insulin loaded carboxylated chitosan grafted poly(methyl methacrylate) nanoparticles.
Cui F; Qian F; Zhao Z; Yin L; Tang C; Yin C
Biomacromolecules; 2009 May; 10(5):1253-8. PubMed ID: 19292439
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and evaluation of lauryl succinyl chitosan particles towards oral insulin delivery and absorption.
Rekha MR; Sharma CP
J Control Release; 2009 Apr; 135(2):144-51. PubMed ID: 19331862
[TBL] [Abstract][Full Text] [Related]
10. Design, characterisation, and bioefficiency of insulin-chitosan nanoparticles after stabilisation by freeze-drying or cross-linking.
Diop M; Auberval N; Viciglio A; Langlois A; Bietiger W; Mura C; Peronet C; Bekel A; Julien David D; Zhao M; Pinget M; Jeandidier N; Vauthier C; Marchioni E; Frere Y; Sigrist S
Int J Pharm; 2015 Aug; 491(1-2):402-8. PubMed ID: 26049075
[TBL] [Abstract][Full Text] [Related]
11. Alginate coated chitosan core shell nanoparticles for oral delivery of enoxaparin: in vitro and in vivo assessment.
Bagre AP; Jain K; Jain NK
Int J Pharm; 2013 Nov; 456(1):31-40. PubMed ID: 23994363
[TBL] [Abstract][Full Text] [Related]
12. Design, characterization and ex vivo evaluation of chitosan film integrating of insulin nanoparticles composed of thiolated chitosan derivative for buccal delivery of insulin.
Mortazavian E; Dorkoosh FA; Rafiee-Tehrani M
Drug Dev Ind Pharm; 2014 May; 40(5):691-8. PubMed ID: 24524272
[TBL] [Abstract][Full Text] [Related]
13. Drug permeability and mucoadhesion properties of thiolated trimethyl chitosan nanoparticles in oral insulin delivery.
Yin L; Ding J; He C; Cui L; Tang C; Yin C
Biomaterials; 2009 Oct; 30(29):5691-700. PubMed ID: 19615735
[TBL] [Abstract][Full Text] [Related]
14. Development of acid-resistant alginate/trimethyl chitosan nanoparticles containing cationic β-cyclodextrin polymers for insulin oral delivery.
Mansourpour M; Mahjub R; Amini M; Ostad SN; Shamsa ES; Rafiee-Tehrani M; Dorkoosh FA
AAPS PharmSciTech; 2015 Aug; 16(4):952-62. PubMed ID: 25604700
[TBL] [Abstract][Full Text] [Related]
15. Oral insulin delivery by self-assembled chitosan nanoparticles: in vitro and in vivo studies in diabetic animal model.
Mukhopadhyay P; Sarkar K; Chakraborty M; Bhattacharya S; Mishra R; Kundu PP
Mater Sci Eng C Mater Biol Appl; 2013 Jan; 33(1):376-82. PubMed ID: 25428084
[TBL] [Abstract][Full Text] [Related]
16. Goblet cell-targeting nanoparticles for oral insulin delivery and the influence of mucus on insulin transport.
Jin Y; Song Y; Zhu X; Zhou D; Chen C; Zhang Z; Huang Y
Biomaterials; 2012 Feb; 33(5):1573-82. PubMed ID: 22093292
[TBL] [Abstract][Full Text] [Related]
17. Preparation and characterization of insulin-loaded bioadhesive PLGA nanoparticles for oral administration.
Zhang X; Sun M; Zheng A; Cao D; Bi Y; Sun J
Eur J Pharm Sci; 2012 Apr; 45(5):632-8. PubMed ID: 22248882
[TBL] [Abstract][Full Text] [Related]
18. Eudragit L-100 Capsules Aromatize and Quaternerize Chitosan for Insulin Nanoparticle Oral Delivery During Toxic Oxidative Stress in Rat Liver and Kidney.
Mahjub R; Najafabadi FK; Dehkhodaei N; Kheiripour N; Ahmadabadi AN; Asl SS; Taheri-Azandariani M; Ranjbar A
Pharm Nanotechnol; 2020; 8(3):239-254. PubMed ID: 32600243
[TBL] [Abstract][Full Text] [Related]
19. Efficient Peroral Delivery of Insulin via Vitamin B12 Modified Trimethyl Chitosan Nanoparticles.
Ke Z; Guo H; Zhu X; Jin Y; Huang Y
J Pharm Pharm Sci; 2015; 18(2):155-70. PubMed ID: 26158281
[TBL] [Abstract][Full Text] [Related]
20. Nanoparticles based on N-trimethylchitosan: evaluation of absorption properties using in vitro (Caco-2 cells) and ex vivo (excised rat jejunum) models.
Sandri G; Bonferoni MC; Rossi S; Ferrari F; Gibin S; Zambito Y; Di Colo G; Caramella C
Eur J Pharm Biopharm; 2007 Jan; 65(1):68-77. PubMed ID: 16962751
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
